Study on the Effect of Sodium Zirconium Cyclosilicate (SZC) on Serum Potassium and Serum Bicarbonate in Patients with High Potassium and Metabolic Acidosis Due to Chronic Kidney Disease (NEUTRALIZE)
Primary Objective
This is a 36 day trial with 8 in-person visits comparing the effect of Lokelma vs. placebo on serum potassium and bicarbonate levels.
Description
Main Procedures Involved: -blood pressure
-blood and urine collection
-EKG
Duration of Participation: 36 days
Details
Age
Adult
Eligibility
-18 years or older -CKD stage 3-5 with GFR of 30-59 -Potassium level of 5.1-5.9 -Carbon dioxide level of 16-20
Type of Study
Treatment
Compensation
Compensation provided
Principal Investigator
Jessica Kendrick, MD
Study ID
Protocol Number: 21-2470
More information available at ClinicalTrials.gov: NCT04727528
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers